- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical safety of ranibizumab in age-related macular degeneration
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 9, Issue 1, Pages 149-165
Publisher
Informa Healthcare
Online
2009-12-15
DOI
10.1517/14740330903418422
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Ranibizumab in Patients with Subfoveal Choroidal Neovascularization Attributable to Age-related Macular Degeneration
- (2009) Simon P. Rothenbuehler et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Vascular endothelial growth factor gene polymorphisms and pregnancy
- (2009) George Galazios et al. Journal of Maternal-Fetal & Neonatal Medicine
- A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration
- (2009) David S. Boyer et al. OPHTHALMOLOGY
- INFECTIOUS ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTIANGIOGENIC AGENTS
- (2009) TERESA DIAGO et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- RETINAL PIGMENT EPITHELIAL TEARS IN RANIBIZUMAB-TREATED EYES
- (2009) BRADLEY T. SMITH et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- SAFETY OF REPEAT INTRAVITREAL INJECTIONS OF BEVACIZUMAB VERSUS RANIBIZUMAB
- (2009) IOANNIS D. LADAS et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Cardiovascular Risk Factors and Age-related Macular Degeneration: The Los Angeles Latino Eye Study
- (2008) Samantha Fraser-Bell et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Short-term Intraocular Pressure Changes Immediately After Intravitreal Injections of Anti–Vascular Endothelial Growth Factor Agents
- (2008) Judy E. Kim et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Endophthalmitis Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy Injections in An Office Setting
- (2008) Suman Pilli et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-related Macular Degeneration (FOCUS): Year 2 Results
- (2008) Andrew N. Antoszyk et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1
- (2008) Carl D. Regillo et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Hospitalized Cardiovascular Diseases in Neovascular Age-Related Macular Degeneration
- (2008) Bao-Anh Nguyen-Khoa ARCHIVES OF OPHTHALMOLOGY
- Combination of verteporfin photodynamic therapy and ranibizumab: effects on retinal anatomy, choroidal perfusion and visual function in the protect study
- (2008) C G Kiss et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Same-day administration of verteporfin and ranibizumab 0.5 mg in patients with choroidal neovascularisation due to age-related macular degeneration
- (2008) U Schmidt-Erfurth et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Retinal pigment epithelial tears after intravitreal bevacizumab injection for exudative age-related macular degeneration
- (2008) Sunir Garg et al. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Risk of Venous Thromboembolism With the Angiogenesis Inhibitor Bevacizumab in Cancer Patients
- (2008) Shobha Rani Nalluri et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vascular Changes After Intra-bleb Injection of Bevacizumab
- (2008) Michael A. Coote et al. JOURNAL OF GLAUCOMA
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
- PREDICTORS OF Anti-VEGF-ASSOCIATED RETINAL PIGMENT EPITHELIAL TEAR USING FA AND OCT ANALYSIS
- (2008) ALLEN CHIANG et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INCIDENCE OF ENDOPHTHALMITIS RELATED TO INTRAVITREAL INJECTION OF BEVACIZUMAB AND RANIBIZUMAB
- (2008) DAVID R. FINTAK et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration
- (2007) Tien Wong et al. OPHTHALMOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation